科学家在1996年发现了被称为具有“死亡配体(death ligand)”功能的蛋白质诱导配体因子(TRAIL),即一种在敏感的细胞表面附着相关受体,能够引发复杂的指令信号而使细胞死亡的蛋白质。
基于22个网页-相关网页
programmed death ligand 及其配体 ; 的配体
programmed cell death ligand 及其配体
programmed death ligand 1 程序性死亡因子配体
programmed death-ligand 1 程序性死亡
programmed death ligand-1 程序性死亡配体
programmed death-1 ligand 及其主要配体 ; 程序性死亡配体
Expression of the immunosuppressive protein B7 homolog 1 (B7-H1), also known as programmed death ligand-1 (PD-L1), is increased in many pathological conditions, including cancer.
免疫抑制蛋白B7同系物1(B7-H1),亦称程序性死亡配体1(PD-L1)在包括癌症等许多病变中表达增高。
Objective to investigate the correlation between sensitivity to tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and expression level of death receptor 5 (DR5) on tumor cell surface.
目的探讨肿瘤细胞表面dr5表达水平与其对肿瘤坏死因子相关的凋亡诱导配体(TRAIL)敏感性之间的关系。
We studied the expression of programmed cell death protein 1 (PD-1) and its ligand (PD-L1) in TNBC.
作者研究了程序性细胞死亡蛋白1(PD-1)及其配体(PD-L1)在三阴性乳腺癌中的表达情况。
应用推荐